InterMune crashes, drags down biotech index – MarketWatch
By Dr. Matthew Watson
 TopNews Singapore (press release) | InterMune crashes, drags down biotech index MarketWatch InterMune's woes also weighed heavily on the NYSE Arca Biotechnology Index (INDEX:BTK) , of which InterMune is a leading component. ... FDA rejects InterMune lung drug, shares fallReuters InterMune's Surprise Rejection Leads Stock to PlummetBusinessWeek InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone ...PR Newswire (press release) |
Uncategorized
Comments Off on InterMune crashes, drags down biotech index – MarketWatch |
May 6th, 2010
This author published 5872 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research